DrugPatentWatch Database Preview
Ampicillin/ampicillin trihydrate - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for ampicillin/ampicillin trihydrate and what is the scope of patent protection?
Ampicillin/ampicillin trihydrate
is the generic ingredient in fourteen branded drugs marketed by Parke Davis, Belcher Pharms, Dava Pharms Inc, Heritage Pharma, Ivax Sub Teva Pharms, Lederle, Mylan, Purepac Pharm, Sandoz, Vitarine, Wyeth Ayerst, Pfizer, Bristol, Apothecon, Bristol Myers Squibb, Glaxosmithkline, Teva, and Cosette, and is included in forty-three NDAs. Additional information is available in the individual branded drug profile pages.Six suppliers are listed for this compound.
Summary for ampicillin/ampicillin trihydrate
| US Patents: | 0 |
| Tradenames: | 14 |
| Applicants: | 18 |
| NDAs: | 43 |
| Suppliers / Packagers: | 6 |
| Bulk Api Vendors: | 103 |
| Clinical Trials: | 1 |
| Patent Applications: | 6,893 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ampicillin/ampicillin trihydrate at DailyMed |
Recent Clinical Trials for ampicillin/ampicillin trihydrate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for ampicillin/ampicillin trihydrate
| Drug Class | Penicillin-class Antibacterial |
US Patents and Regulatory Information for ampicillin/ampicillin trihydrate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dava Pharms Inc | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 062883-001 | Feb 25, 1988 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Apothecon | POLYCILLIN | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 062297-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Teva | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 061370-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Bristol | POLYCILLIN | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 050310-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Wyeth Ayerst | OMNIPEN (AMPICILLIN) | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 060625-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Apothecon | PRINCIPEN '250' | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 062151-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Apothecon | PRINCIPEN '125' | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 060127-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
